{"data":{"id":"us/37-cfr-1.833","jurisdiction":"us","citation":"37 CFR 1.833","heading":"Requirements for a “Sequence Listing XML” for nucleotide and/or amino acid sequences as part of a patent application filed on or after July 1, 2022.","body":"(a) The “Sequence Listing XML” as required by § 1.831(a) must be presented as a single file in XML 1.0 encoded using Unicode UTF-8, where the character set complies with paragraphs 40 and 41 and Annex IV of WIPO Standard ST.26 (incorporated by reference, see § 1.839).\n(b) The “Sequence Listing XML” presented in accordance with paragraph (a) of this section must further:\n(1) Be valid according to the Document Type Definition (DTD) as presented in WIPO Standard ST.26, Annex II.\n(2) Comply with the requirements of WIPO Standard ST.26 to include:\n(i) An XML declaration as defined in paragraph 39(a) of WIPO Standard ST.26;\n(ii) A document type (DOCTYPE) declaration as defined in paragraph 39(b) of WIPO Standard ST.26;\n(iii) A root element as defined in paragraph 43 of WIPO Standard ST.26;\n(iv) A general information part that complies with the requirements of paragraphs 45, 47, and 48, as applicable, of WIPO Standard ST.26; and\n(v) A sequence data part that complies with the requirements of paragraphs 50-55, 57, 58, 60-69, 71-78, 80-87, 89-98, and 100, as applicable, of WIPO Standard ST.26 representing the nucleotide and/or amino acid sequences according to § 1.832.\n(3) Include an INSDQualifier__value element with a value in English for any language-dependent free text qualifier as defined by paragraphs 76 and 85-87 of WIPO Standard ST.26, and as required by § 1.52(b)(1)(ii).","path":["Title 37—Patents, Trademarks, and Copyrights","CHAPTER I—UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF COMMERCE","SUBCHAPTER A—GENERAL","PART 1—RULES OF PRACTICE IN PATENT CASES","Subpart G—Biotechnology Invention Disclosures"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-37.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:25:45Z","sha256":"4c62b49746fe40038212b37c4e1fcad63501fd6cad81121ed468d4622582bb12","source_id":"us-cfr","stale":true,"prev":"us/37-cfr-1.832","next":"us/37-cfr-1.834"},"notice":"GroundRules: Original legal text. Not legal advice."}